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Abstract
Background: A 32-year-old Caucasian man presented with intractable nausea, psychogenic vomiting, abdominal pain and compulsive 
hot-water bathing behaviors following the habitual use of cannabis for years, consistent with the uncommon and frequently overlooked 
diagnosis of Cannabinoid Hyperemesis Syndrome. This was his third admission to the emergency department with the same complaints 
and symptoms which had persisted for over two years without a recognizable etiology. All imaging studies done on each visit were unre-
markable. Results: The patient was clinically symptomatic with the aforementioned presenting complaints, but disappeared upon discon-
tinuation of the cannabis. Within two days of supportive treatment in addition to temporary relief of symptoms with bathing. To date, no 
effective cure has been sought for this unique diagnosis other than abstaining from cannabis use. Conclusion: A complete recovery was 
made three days following admission. The presenting symptoms were attributed to the smoking behaviors. The patient was followed up 
by his primary care physician once released from the hospital. A very rare diagnosis surfaced a number of times with the same patient 
in the same setting over the span of a couple years, but was overlooked due to its rarity. Hence, physicians should list it higher on their 
differentials when dealing with a patient with a history of drug abuse.
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Introduction
Cannabinoid Hyperemesis Syndrome (CHS) was first noted by 
Allen JH, and De Moore GM, when they explored the association 
between chronic cannabis abuse and a cyclical vomiting illness 
that presented in a series of cases in South Australia in 2004.1 
It is a syndrome characterized by the chronic use of canna-
bis, recurrent episodes of severe nausea, vomiting, abdominal 
pain, and habitual bathing behaviors to help resolve symp-
toms (a pathognomonic feature). The mechanisms explaining 
the adverse consequences of long-term cannabis toxicity re-
main largely unknown, however various pathogenic mechanis-
tic theories maintain that several peripheral CB1 cannabinoid 
receptors in the brain are responsible for the presenting signs 
and symptoms.1 Almost a decade has passed since the first 
published case of CHS and yet in the emergency department, 
this peculiar disease remains obscure and under diagnosed. In 
fact, before a case series published by Simonetto et al., at the 
Mayo Clinic in 2012 recognizing 98 patients afflicted with the 
syndrome, only 33 cases of CHS was published.2 Since the first 
aforementioned documentation and with the recent legaliza-
tion of medical marijuana in numerous states, the syndrome 
has now surfaced across North America, Western Europe and 
Australia.3
The Case
A 32 year old male presented to the Dekalb Medical Center 
Emergency Department in Atlanta, Georgia for nausea, non-
bloody vomiting, and diffuse colicky abdominal pain over the 
course of a week. Food intake exacerbated his condition and 
his nausea was relieved by taking hot showers.  Patient ad-
mitted to smoking half a pack of cigarettes per day as well as 
smoking up to five blunts of cannabis a day for the past six 
years. The rest of the review of systems was noncontributory. 
On physical examination, his blood pressure was 140/90, his 
pulse rate was 104/min and his mucous membranes were dry. 
The remainder of the physical examination, his complete blood 
count, comprehensive metabolic panel and arterial blood gas 
were all unremarkable. Serum amylase and lipase levels were 
within therapeutic range. His urine drug screen was positive 
for tetrahydrocannabinol (THC). It was later noted that these 
symptoms had persisted for over 2 years and the patient had 
been admitted with the same complaints three times to the 
same emergency department. Each time, abdominal X-Rays, CT 
scans, ultrasounds, esophagogastroduodenoscopies, colonos-
copies, and stool studies were performed and were all unre-
markable. No previous interventions were noted on each visit. 
In his third and final admission, the clinical diagnosis of CHS 
was made. Treatment was supportive with fluid hydration and 
rest. The patient abstained from cannabis use for the duration 
of his stay in the hospital until discharge three days later.
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          Key Points:
• The low number of reported cases despite the pathognomonic features 
of the syndrome render CHS rather difficult to diagnose clinically.
• As cannabinoids are supposed antiemetics, their habitual use leading to 
vomiting as one of the more potent side effects is a conundrum.
• The ironic nature of the syndrome has led to theories being proposed 
regarding its mechanism, but none of the hypotheses have been confir-
med to date.
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Discussion
It has been noted that It takes up to an average of seven visits 
before patients with chronic vomiting are diagnosed with any 
underlying cause.4 In fact, in a survey conducted by Venkate-
san T, et al., revealed that 89% of the patients with chronic 
vomiting were not diagnosed in the emergency department.3 
Emergency medicine physicians may be hesitant to place the 
diagnosis of CHS high on their differentials for the following 
reasons:
CHS is a rare diagnosis: As mentioned previously, up until two 
years ago, few cases had been published for CHS.2 Although 
this low number suggests that the diagnosis is uncommon, 
medical professionals and cannabis users may not be cons-
cious of the diagnostic symptoms. Consequently, a significant 
number of cases might be unrecognized. Here a case of can-
nabis use was described where the patient presented multiple 
times with the same complaints and an exhaustive medical 
evaluation failed to reveal another etiology. Several common 
differentials for nausea and vomiting were considered inclu-
ding overdoses of alcohol or medications, bacterial and viral 
infections, inflammatory gastrointestinal diseases, and central 
nervous system or psychiatric conditions. However, no eviden-
ce supported any of the aforementioned causes.
CHS is a paradoxical diagnosis: Cannabinoids are medically 
used antiemetics for the prevention of nausea and vomiting 
caused by chemotherapy via a mechanism inhibiting the re-
lease of emetic neurotransmitters by stimulating presynaptic 
cannabinoid CB1 receptors.5 Hence, cannabinoids inducing 
hyperemesis appears to be contradictory and the pathophy-
siological mechanism(s) underlying the induced vomiting is 
still unknown, therefore obscuring the role of cannabinoid in 
patients with hyperemesis. 
CHS is an under-researched diagnosis: The pathognomonic fea-
ture of CHS of compulsive warm water bathing for temporary 
relief of symptoms has no definite explanation. The CB1 re-
ceptor is near the thermoregulatory center of the hypothala-
mus and chronic stimulation may be counteracted with warm 
showers, but to date, this theory has yet to be verified.6 Alter-
nate explanations theorize that CB1 receptor-mediated vasodi-
lation of the gut with chronic cannabis use may contribute to 
the symptoms. A redistribution of blood flow from the gut to 
the skin with hot water could bring relief to the patient in a 
“cutaneous steal syndrome” pattern.2
The aforementioned case series published in 2012 by Simonetto 
et al., identified 98 patients who met inclusion criteria for diag-
nosis – recurrent vomiting with no other explanation for symp-
toms, cannabis use preceding symptom onset and absence of 
major illness that could explain the symptoms. To further refine 
the decisive factors, the authors have now expanded the flow 
chart to include relief of symptoms with hot showers or baths, 
resolution with cannabis cessation, several cycles of nausea 
and vomiting, abdominal, epigastric or periumbilical pain, wee-
kly use of marijuana, age under 50, weight loss greater than 
5 kg, normal bowel habits, negative laboratory, radiographic, 
and endoscopic test results with a morning predominance of 
presenting symptoms.2 These can all further aid ED physicians 
in formulating their differentials when confronted with patients 
who present with similar symptoms to rule out differentials 
such as gastroesophageal reflux disease, peptic ulcer disea-
se, inflammatory bowel disease, appendicitis and pancreatitis 
among other gastrointestinal diseases high on the possible 
diagnoses without colonoscopies, endoscopies, esophagogas-
troduodenoscopies and imaging studies to aid them. Still, stu-
dies with lower attrition rates are needed and validation of the 
proposed diagnostic criteria is required. 
Conclusion
The use of cannabis has become more prominent and it is 
slowly gaining notoriety as one of the most commonly abused 
drugs worldwide. In fact, an estimated 2.6 million individuals in 
the USA become new users every year.7 Though further studies 
are warranted to further understand the prevalence and symp-
toms of this uncommon disease, CHS should be considered hi-
gher on the differential list when patients present with chronic 
vomiting with no underlying etiology given the widespread and 
continuously rising use of cannabis today. With an accurate 
history and knowledge of this phenomenon, expensive and in-
vasive diagnostic treatment can be avoided.
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